ArticleGastroenterology2022

HNF4A Defines Molecular Subtypes and Vulnerability to Transforming Growth Factor β-Pathway Targeted Therapies in Cancers of the Distal Esophagus.

Andrew E Blum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.